The effect of Vernonia cinerea Less. extract on the inhibition of lung metastasis induced by B16F-10 melanoma cells was studied in C57BL/6 mice. V cinerea extract significantly (P < .001) inhibited lung tumor formation (78.8%) and significantly increased the life span (72.5%). Moreover, lung collagen hydroxyproline, uronic acid, and hexosamine and also serum sialic acid, γ-glutamyltransferase (GGT), and vascular endothelial growth factor (VEGF) levels were found to be significantly (P < .001) lower in treated animals compared with untreated controls. Histopathological analysis of the lung tissues also correlated with these findings. V cinerea treatment significantly inhibited the invasion of B16F-10 melanoma cells across the collagen matrix of the Boyden chamber. V cinerea also inhibited the migration of B16F-10 melanoma cells across a polycarbonate filter in vitro. It downregulated the production and expression of proinflammatory cytokines such as TNF (tumor necrosis factor)-a, IL (interleukin)-1b, IL-6, and GM-CSF (granulocyte monocyte colony-stimulating factor). V cinerea extract administration could suppress or downregulate the expression of matrix metalloproteinase (MMP)-2, MMP-9, lysyl oxidase, prolyl hydroxylase, K-ras, extracellular signal-regulated kinase (ERK)-1, ERK-2, and VEGF and also upregulate the expression of nm-23, tissue inhibitor of metalloproteinase (TIMP-1), and TIMP-2 in the lung tissue of metastasis-induced animals. It also inhibited the protein expression of MMP-2 and MMP-9 in gelatin zymographic analysis of B16F-10 cells. These results indicate that V cinerea could inhibit the metastatic progression of B16F-10 melanoma cells in C57BL/6 mice by regulating MMPs, VEGF, prolyl hydroxylase, lysyl oxidase, ERK-1, ERK-2, TIMPs, nm23, and proinflammatory cytokine gene expression in metastatic lung tissue.
Introduction
Cancer is recognized worldwide to be a major health problem. Metastasis, a hallmark of cancer, is the primary cause of death for most cancer patients. It is the single most important obstacle to curative cancer therapy. Although there are several drugs available to counter cancer growth in humans, there are no drugs presently available to specifically inhibit the metastasis of cancer cells. There is a cascade of events leading to the metastasis of tumors, where tumor cells disseminate from the primary tumor, migrate through the basement membrane, survive in the circulatory system, invade into a secondary site, and start to proliferate. 1, 2 Any drug that can inhibit one of the steps in the cascade will be useful in the inhibition of tumor metastasis.
The metastatic process comprises multiple events involving cell motility, cell invasion, surface adhesion properties, and degradation of the extracellular matrix (ECM). 3 Thus, degradation of the ECM and components of the basement membrane caused by a concerted action of proteinases, such as matrix metalloproteinases (MMPs) play a critical role in tumor invasion and metastasis. 4, 5 MMP-2 (gelatinase A) and MMP-9 (gelatinase B) are type IV collagenases that degrade basement membrane collagen. 6 MMP activity is usually closely regulated by endogenous inhibitors. The best characterized of these are the tissue inhibitors of metalloproteinases (TIMPs). Their inhibitory activity results from the formation of a noncovalent complex of the TIMPs to the C-terminal domain of the pro-MMPs. 7, 8 MMPs are also necessary for releasing proangiogenic factors like vascular endothelial growth factor (VEGF). 9 VEGF is overexpressed by tumor cells and plays an important role in the process of neovascularization and metastasis. 10 VEGF acts on endothelial cells to induce cell migration and proliferation. 11, 12 Compounds that block or suppress the metastatic cascade have potential as anticancer agents. Therefore, it is essential to search for novel antimetastatic agents that are efficient and have minimum side effects.
Several inflammatory cytokines have been linked with carcinogenesis and tumor initiation, promotion, and metastasis, which suggests that inflammation is associated with cancer development. 13 Numerous studies have indicated that tumor cells exhibit an elevation in constitutive production of proinflammatory cytokines such as TNF (tumor necrosis factor)-a, IL (interleukin)-1b, IL-6, and GM-CSF (granulocyte monocyte colony stimulating factor). [14] [15] [16] [17] The secretion of lysyl oxidase and prolyl hydroxylase, 2 enzymes that favor collagen biosynthesis has been shown in various cancer cell lines. 18, 19 The increased expression of lysyl oxidase and prolyl hydroxylase suffices to induce collagen accumulation and fibrosis. 20, 21 Medicinal plants have a long history of use in the treatment of cancer. 22 We have already reported the antimetastatic activities of several herbal preparations. [23] [24] [25] [26] Vernonia cinerea Less. (Asteraceae) has many therapeutic uses in different traditional medicines all over the world. Different parts of the plant have different therapeutic value. To mention a few, the plant is used for malarial fever, worms, pain, infections, diuresis, cancer, abortion, and various gastrointestinal disorders. [27] [28] [29] [30] [31] [32] [33] We have reported that V cinerea showed antioxidant, immunomodulatory, and chemoprotective effects in mice. [34] [35] [36] Phytochemical analysis of V cinerea showed the presence of steroids, triterpenoids, sesquiterpenes, flavonoids, and tannins. [37] [38] [39] [40] Vernolide-A and vernolide-B are new sesquiterpene lactones reported in this plant. Biological evaluation showed that vernolide-A has potent cytotoxicity against human KB, DLD-1, NCI-661, and HeLa tumor cell lines. Vernolide B had marginal cytotoxicity against KB, NCI-661, and HeLa tumor cell lines. 41 In the present study, for the first time, we report the antimetastatic activity of V cinerea extract and its mechanism of action using in vivo and in vitro models.
Materials and Methods Animals
C57BL/6 mice (20-25 g body weight, 6-to 8-weeks-old males) were purchased from the National Institute of Nutrition, Hyderabad, India. The animals were fed with mouse chow (Sai Feeds, India) and water ad libitum. All the animal experiments were carried out with the prior approval of the Institutional Animal Ethics Committee and were conducted strictly adhering to the guidelines of Committee for the purpose of Control and Supervision of Experiments on Animals constituted by the Animal Welfare Division of Government of India.
Cell Line
B16F-10 melanoma, a highly metastatic cell line was obtained from the National Centre for Cell Sciences, Pune, India. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal calf serum and antibiotics.
Chemicals
DMEM was obtained from Himedia (Mumbai, India). Fetal bovine serum was procured from Life Technologies (Grand Island, NY). MTT-3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide-hydroxyproline and glucuronic acid lactone were purchased from Sigma Chemicals (St Louis, MO). N-acetyl neuraminic acid was purchased from Sisco Research Laboratory, Mumbai, India. Oligonucleotide primer sequences were purchased from Maxim Biotech Inc (San Francisco, CA; Table 1 ). Radioactive thymidine ( 3 H) was purchased from BRIT (Mumbai, India). All other reagents were of analytical grade.
ELISA Kits
Highly specific quantitative sandwich ELISA kit for mouse IL-1b, IL-6, TNF-a, and GM-CSF were purchased from Pierce Biotechnology, Rockford, IL, and ELISA kit for VEGF was purchased from R & D system, USA.
Drug Preparation
V cinerea was collected locally and a voucher specimen with number ACRC/Astr-08 was deposited at the herbarium of Amala Ayurveda Research Centre (Kerala, India) after authentication. The whole plant was dried at 45°C and powdered. It was then extracted with 70% methanol in soxhlet apparatus, and the extract was evaporated to dryness. The yield of the extract was 17%. The extract was redissolved in minimum amount of DMSO (dimethyl sulfoxide) for in vitro studies. For animal experiments, it was resuspended in 1% gum acacia, and based on the toxicity studies, a nontoxic concentration of 20 mg/kg body weight was selected and administered intraperitoneally.
Antimetastatic Activity in the In Vivo System
Lung tumor nodule formation and rate of survival. C57BL/6 mice were divided into 2 groups (14 per group). All the animals were injected with B16F-10 melanoma cells (10 6 cells/animal) through the lateral tail vein. 42 Group I animals were administered V cinerea extract (20 mg/kg body weight, intraperitoneally) simultaneously with metastatic tumor cells, and this was continued for 10 consecutive days. Group II animals were kept as untreated metastatic tumor-bearing controls. Then, 8 animals from each group were killed on the 21st day after tumor challenge; blood was collected and lungs were excised and weighed, and the surface lung tumor nodules were counted.
The excised lungs were used to estimate the lung collagen hydroxyproline, lung hexosamine, and lung uronic acid contents and for histopathological analysis. Lung collagen hydroxyproline was determined by the method of Bergman and Loxley. 43 The lungs were homogenized, protein precipitated with TCA, and hydrolyzed using 6 N HCl. The hydrolysate was evaporated to dryness and the residue dissolved in water and used for assay by the chloramine-T method. A standard graph was plotted using a hydroxyproline standard.
The hexosamine content in the lung tissue was estimated by the method of Elson and Morgan. 44 Lyophilized tissue samples were hydrolyzed with 2 N HCl, and the hydrolysate evaporated to dryness. The residue was dissolved in water and treated with 2% acetyl acetone. Hexosamine was estimated in the presence of Ehrlich's reagent. A standard graph was plotted using a glucosamine standard.
The uronic acid content present in the lungs was estimated by the method of Bitter and Muir. 45 The lungs were digested with crude papain and hydrolyzed. The hydrolysate 
Forward 5′-ATGAAGTTCCTCTCTGCAAGAGAC-3′ 638 Reverse 5′-CACTAGGTTTGCCGAGTAGATCTC-3′ GM-CSF Forward 5′-TGTGGTCTACAGCCTCTCAGCAC-3′ 368 Reverse 5′-CAAAGGGGATATCAGTCAGAAAGGT-3′ GAPDH Forward 5′-CGTCCCGTAGACAAAATGGT-3′ 527 Reverse 5′-CCTTCCACAATGCCAAAGTT-3′ Abbreviations: bp, base pairs; ERK, extracellular signal-regulated kinase; VEGF, vascular endothelial growth factor; TNF, tumor necrosis factor; MMP, matrix metalloproteinase; IL, interleukin; GM-CSF, granulocyte monocyte colony-stimulating factor; GAPDH, reduced glyceraldehyde phosphate dehydrogenase.
was treated with sulfuric acid. The uronic acid level was estimated in the presence of carbazole reagent at 530 nm. A standard graph was plotted using glucuronic acid lactone.
Blood was collected by heart puncture, serum separated, and used to estimate serum sialic acid and γ-glutamyl transpeptidase levels. Protein-bound serum sialic acid levels were estimated by thiobarbituric acid assay. 46 The serum was hydrolyzed using 0.2 N sulfuric acid. The hydrolysate was oxidized with periodic acid and incubated at 37°C for 1 minute. After terminating oxidation using sodium arsenate, 6% thiobarbituric acid was added. Sialic acid was estimated at 549 nm with reference to 632 nm after adding DMSO. Sialic acid content was determined from the standard graph plotted using NANA.
Serum γ-glutamyl transpeptidase levels were estimated by measuring the release of p-nitro aniline from γ-glutamyl p-nitroanilide in the presence of an acceptor (glycylglycine). 47 The GGT content was determined from the graph plotted using a p-nitro aniline standard.
Serum VEGF was estimated using a highly specific ELISA kit purchased from R&D System, USA, as per manufacturer's protocol. The remaining 6 animals in each group were observed for their survival. The mortality of the animals was observed and the percentage increase in life span (%ILS) was calculated using the formula %ILS = [(T -C)/C] × 100, where T represents the number of survival days of treated animals, and C represents the number of survival days of control animals.
Serum cytokine level. A similar set of experiments were set up as mentioned above, and blood was collected from each animal on the 21st day after B16F-10 transplantation. Serum was separated and used for the estimation of various cytokine (IL-1b, TNF-a, IL-6, and GM-CSF) levels using ELISA kits according to manufacturer's instructions.
Histopathological analysis. Lung tissues were fixed in 10% formalin, dehydrated in different concentrations of alcohol and embedded in paraffin wax. Sections (4 mm) were stained with eosin and hematoxylin.
Expression studies. Total RNA was isolated from the lungs, and cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase. Amplification was performed using specific primers of MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, k-ras, extracellular signalregulated kinase (ERK)-1, ERK-2, nm23, TIMP-1, TIMP-2, and proinflammatory cytokines, such as TNF-a, IL-1b, IL-6, and GM-CSF ( Table 1 ). The amplified products were electrophoresed on a 1.8% agarose gel, stained with ethidium bromide, and photographed under ultraviolet light.
Antimetastatic Activity Using In Vitro Models
Cell viability. B16F-10 melanoma cells were seeded (5000 cells/well) in 96-well flat-bottomed titer plates and incubated for 24 hours at 37°C in 5% CO 2 atmosphere. Different concentrations of V cinerea extract (0.01-10 mg/mL) were added and incubated further for 48 hours. Before 4 hours of completion of incubation, 20 mL MTT (5 mg/mL) was added. 48, 49 All concentrations were done in triplicate. The percentage of dead cells was determined using an ELISA plate reader set to record absorbance at 570 nm.
Proliferation assay. B16F-10 melanoma cells (5000 cells/ well) were plated in a 96-well culture plate and incubated at 37°C in 5% CO 2 atmosphere. After 24 hours, various concentrations of V cinerea extract (0.5, 1, 2 mg/mL) were added and further incubated for 48 hours. 3 H-thymidine was added to each well (1 mCi/well), and incubation was continued for an additional 18 hours. After completing incubation, the plates were centrifuged, and the culture supernatant was removed; the cells were washed 3 times with phosphatebuffered saline and then treated with ice-cold perchloric acid (PCA) for 15 minutes. The resulting precipitate was dissolved in 0.5 N NaOH and was added to the scintillation fluid and kept overnight in the dark. The radioactivity was counted using a Rack Beta liquid scintillation counter.
Collagen matrix invasion assay. The invasion assay was carried out in modified Boyden chambers as described by Albini et al. 50 The lower compartment of the chamber was filled with serum-free DMEM, and a polycarbonate filter coated with 25 mg Type I collagen was placed above this. B16F-10 melanoma cells (10 5 cells/150 mL DMEM) were then seeded on to the upper chamber in the presence and absence of V cinerea extract (0.5, 1, and 2 mg/mL) and incubated at 37°C in 5% CO 2 atmosphere for 10 hours. After incubation, the filters were removed, fixed with methanol, and stained with crystal violet. Cells migrating to the lower surface of the polycarbonate filters were counted under a microscope. The results were expressed as percentage inhibition of invasion. Experiments were done in triplicate.
Migration assay. The effect of V cinerea extract on the migration of the tumor cells was carried out using the Boyden chamber. The polycarbonate filters were placed in Boyden chambers. The lower compartment of the chamber was filled with serum-free DMEM, and B16F-10 cells (10 5 cells/chamber) in DMEM were then seeded on to the upper chamber in the presence and absence of V cinerea extract (0.5, 1, and 2 mg/mL) and incubated for 10 hours at 37°C in 5% CO 2 . The number of migrated cells in the lower compartment was measured by hemocytometer counting.
Gelatin zymography. SDS-PAGE was performed with 5% gelatin incorporated in the separating. 51 B16F-10 melanoma cells of subconfluent cultures were incubated with serum-free medium for 24 hours at 37°C in 5% CO 2 atmosphere. The conditioned medium was then collected and subjected to zymographic analysis. Then, 50 mL of sample (equivalent to 100 mg protein) was activated with 5 mL trypsin solution (75 mg/mL) in the presence and absence of V cinerea extract (0.5, 1, and 2 mg/mL) in 0.1 M Tris-HCl, 10 mM CaCl 2 buffer (pH 8.0) and incubated for 1 hour at room temperature. Samples were mixed with an equal volume of 2 × sample buffer and loaded on to 11% polyacrylamide gels containing 5% gelatin. Electrophoresis was carried out at 4°C with constant current of 2 mA/tube until the tracking dye reached the periphery. The gels were then washed with 2% Triton X-100 in 0.1 M Tris-HCl, 10 mM CaCl 2 at 37°C for 18 hours followed by staining with Gel-Code Blue stain reagent for 2 hours. Gels were destained to visualize the clear area against the dark background.
Statistical Analysis
Values were expressed as mean ± standard deviation. The statistical analysis was done using 1-way ANOVA followed by Dunnett's test.
Results

Antimetastatic Activity in the In Vivo System
Lung tumor nodule formation and rate of survival. Earlier it had been reported that B16F-10 cells mainly form lung tumors. 52 The effect of V cinerea on the inhibition of pulmonary tumor nodules is shown in Table 2 . Lung weight was increased in untreated metastatic controls (302 ± 41 mg) compared with the normal lung (175 ± 15 mg), which was significantly (P < .01) reduced in the V cinerea-treated group (216 ± 32 mg). There was a significant (P < .001) reduction in the lung tumor nodule formation when the animals were treated with V cinerea (78.8%) and tumor cells simultaneously. Untreated control animals developed massive numbers of tumor nodules on their lungs and were assigned an arbitrary number of 250. 42 The survival rate of the animals was also increased to 72.5% by simultaneous treatment with the extract ( Table 2 ).
Effect of Treatment on the Biochemical Parameters of Metastases-Bearing Animals
Lung collagen hydroxyproline. The effect of V cinerea treatment on the biochemical parameters of the lung is shown in Table 3 . The lung collagen hydroxyproline content was drastically elevated (22.56 ± 2.41 mg/mg protein) in the control group compared with normal levels (1.42 ± 0.22 mg/mg protein), indicating fibrosis of lung tissue. This elevated level was significantly (P < .001) reduced to 10.53 ± 1.4 mg/mg proteins by simultaneous treatment with V cinerea.
Lung hexosamine content. The control animals had a high level of lung hexosamine content (4.26 ± 0.49 mg/100 mg tissue, dry weight) as compared with normal animals (0.52 ± 0.14 mg/100 mg tissue, dry weight). Simultaneous administration of the drug could significantly (P < .001) reduce this level to 1.43 ± 0.38 mg/100 mg tissue dry weight (Table 3 ). The lungs were dissected out and observed for metastases on the 21st day after induction of B16F-10 melanoma (106 cells). Tumor induction was done through the lateral tail vein. Drug administration started simultaneously with tumor challenge for 10 consecutive days. Animals were killed on the 21st day; the lungs were weighed, and tumor nodules were counted. Values are given as mean ± standard deviation. *P < .001; **P < .01. Data were compared with respective controls. b An arbitrary number of 250 is given for massive number of tumor nodules. B16F-10 melanoma cells were administered through the lateral tail vein (10 6 cells). On the 21st day of tumor induction, lungs were dissected out, and the levels of lung OH-proline, hexosamine, and uronic acid were determined. Values are given as mean ± standard deviation. *P < .001.
Uronic acid levels of the lung. As in the case of hydroxyproline and hexosamines, uronic acid level in the lung of control animals (324.81 ± 12.8 mg/100 mg tissue, wet weight) was also very high as compared with normal levels (36.60 ± 4.82 mg/100 mg tissue, wet weight). The V cinerea (112.61 ± 10.2 mg/100 mg tissue) could significantly (P < .001) reduce these elevated levels when administered simultaneously with the tumor cells (Table 3) .
Serum sialic acid levels. Effect of drug treatment on the serum biochemical parameters is shown in Table 4 . The normal serum sialic acid level of C57BL/6 mice was 24.83 ± 2.64 mg/mL, which was elevated to 112.52 ± 8.31 mg/mL serum in the metastases-bearing animals. Simultaneous administration of V cinerea significantly (P < .001) reduced the sialic acid levels to 41.26 ± 3.51 mg/mL serum.
Serum γ-glutamyltranspeptidase (γ-GT). γ-GT activity in the control animals was very high (115.61 ± 6.14 U/l) as compared with the γ-GT level in the serum of normal animals (3.7 ± 0.4 U/l). Simultaneous administration of V cinerea significantly (P < .001) reduced the elevated levels to 46.82 ± 4.38 U/L serum (Table 4) .
Serum VEGF levels. Serum VEGF levels are shown in Serum cytokine level. In Table 5 , we show the effect of V cinerea on serum cytokine levels in metastatic tumor-bearing mice. Levels of cytokines such as TNF-a, IL-1b, IL-6, and GM-CSF were elevated in the serum of metastases control animals, and they were significantly (P < .001) reduced by the simultaneous administration of V cinerea.
Histopathological Analysis of the Lung
The hematoxylin and eosin (H&E)-stained sections of lung tissues are shown in Figure 1 (100×) . In the control animals, massive tumor growth and fibrosis reduced the alveolar space, thereby, reducing the vital capacity of the lung. The same areas were characterized by necrosis around the alveolar passages and bronchioles. Simultaneous administration of the V cinerea showed a reduction in tumor mass around the alveoli and pleura.
V cinerea inhibits MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, k-ras, ERK-1, and ERK-2 expression in metastatic lungs. The mRNA expression of prometastatic genes such as MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, k-ras, ERK-1, and ERK-2 was found to be upregulated in the lung tissue of metastatic-tumor control animals. It was interesting to note that the expression of these genes was downregulated or inhibited in the lung tissue of mice treated with V cinerea (Figure 2 ).
V cinerea stimulates nm23, TIMP-1, and TIMP-2 expression in metastatic lungs. Figure 3 shows the mRNA expression of antimetastatic genes, nm23, TIMP-1, and TIMP-2. Expressions of these genes were absent or downregulated in metastatic tumor-bearing animals. The present result indicates that V cinerea treatment could increase the mRNA expression of these genes. B16F-10 melanoma cells were administered through the lateral tail vein (10 6 cells). On the 21st day of tumor induction, blood was collected by heart puncture and serum separated to determine the levels of sialic acid, GGT, and VEGF. Drug administration was started simultaneously with tumor induction (10 doses at 24-hour intervals intraperitoneally. Values are given as mean ± standard deviation. *P < .001. V cinerea inhibits the expression of proinflammatory cytokines TNF-a, IL-1b, IL-6, and GM-CSF. Proinflammatory cytokine expression is shown in Figure 4 . Tissue mRNA expression of proinflammatory cytokines such as TNF-a, IL-1b, IL-6, and GM-CSF were increased in metastatic tumor-bearing control animals. Treatment with V cinerea could inhibit or downregulate the mRNA expression of these genes.
Determination of Antimetastatic Activity in the In Vitro System
Cell viability assay. Cytotoxicity of V cinerea toward B16F-10 melanoma cells in culture is shown in Table 6 . At 0.5 to 2 mg/mL, V cinerea was found to be nontoxic to B16F-10 melanoma cells, and these concentrations were used for further in vitro experiments.
Tumor cell proliferation. The proliferation rate was determined by 3 H-thymidine incorporation by the DNA of B16F-10 melanoma cells. Thymidine incorporation is proportional to the potential of the cells to synthesize DNA. Proliferation was expressed as radioactive counts per minute. Untreated B16F-10 cells had a very high rate of proliferation (4652.6 ± 262 cpm). Administration of V cinerea at a concentration of 2 mg/mL significantly (P < .001) reduced (1884.7 ± 216 cpm, 59.49 %) the proliferation of B16F-10 melanoma cells. Considerable inhibition of proliferation was also observed ( Table 7) when V cinerea was administered at concentrations of 1 mg/mL (2561.8 ± 206 cpm; 44.93%) and 0.5 mg/mL (3495.7 ± 236 cpm; 24.86%).
Collagen matrix invasion assay. Metastatic B16F-10 melanoma cells are highly invasive through the collagen matrix. Very high numbers of cells were found in the lower surface of the polycarbonate membrane, but administration of V cinerea produced significant inhibition in the invasion of the collagen matrix by the tumor cells, in a dose-dependent manner. At a concentration of 2 mg/mL, V cinerea significantly inhibited the invasion of B16F-10 melanoma cells by 82.52% ± 9.4%, whereas at 1 and 0.5 mg/mL, the percentage of inhibition of invasion was found to be 68.61% ± 7.6% and 26.83% ± 4.2%, respectively ( Figure 5) .
Migration. Inhibition of tumor cell migration by V cinerea is shown in Figure 6 . V cinerea significantly inhibited the migration of B16F-10 melanoma cells across the polycarbonate filters in a dose-dependent manner.
Gelatin zymographic analysis. V cinerea inhibited the activation of MMPs produced by B16F-10 melanoma cells as shown in Figure 7 . The conditioned medium after trypsin activation showed digested clear areas at 92 and 72 kD, which were identical to MMP-9 and MMP-2 activity ( Figure 7B ). Gels loaded with condition medium, without trypsin activation, did not show any clear areas, indicating the inactive form of the enzyme collagenase ( Figure 7A ). Trypsin-activated condition medium-loaded gels after incubation with 10 mM EDTA did not show clear areas, were added, and incubation was continued for 48 hours. After incubation, 3H-thymidine was added to each well (1 mCi/well), and incubation was continued for 18 hours. Cells were lysed, and radioactivity was counted by using a Rack Beta liquid scintillation counter. Values are given as mean ± standard deviation. *P < .001; ** P < .01.
which indicates that the enzyme responsible for degradation is metalloproteinase ( Figure 7C ). When the conditioned medium was treated with V cinerea during trypsin activation, no clear bands were observed ( Figures 7D and 7E) , indicating that V cinerea inhibited the activation of procollagenase to active collagenase at concentrations of 2 and 1 mg/mL. Condition medium treated with V cinerea at 0.5 mg/ mL showed 2 faded bands ( Figure 7F ).
Discussion
The essential characteristics of cancer cells are the ability to invade surrounding tissues and metastasize to regional and remote sites. Metastases are the cause of 90% of human cancer deaths. It is not a passive process but involves strict upregulations and downregulations in the expression of specific genes. Metastasis is an exceedingly complex process, which occurs through a series of sequential steps that include the invasion of adjacent tissues, intravasation, transport through the circulatory system, arrest at a secondary site, extravasation, and growth in a secondary organ. 53 Therapeutic treatment modalities of chemotherapy, radiotherapy, and surgery, although effective for some patients with solid malignancies cannot be successfully used for others with progressive outgrowth of metastasis. 54 Highly malignant tumor cell subpopulations are often resistant to therapy with chemotherapeutic, cytoreductive anticancer drugs. 55, 56 Cisplatin and other drugs used in conventional cancer chemotherapy are limited by their serious side effects that include nephrotoxicity and peripheral neuropathy. The key factor for toxicities is immune suppression. Because of these acute toxicities, it has become necessary to develop second-generation drugs, which are equally effective but less toxic. 57 The use of natural products against metastasis is less toxic and more effective. Natural herbal medicines have been used clinically to treat cancer patients, or they have been used as adjuvant therapy because they have minimal side effects and can also decrease the side effects of chemotherapy and/or radiotherapy. 58 In the present study, we analyzed the antimetastatic activity of V cinerea extract and its mechanism of action. B16F-10 melanoma cells are highly metastatic and form colonies of tumor nodules in the lungs when administered through the tail vein, which in turn promote lung fibrosis and collagen deposition. The methanolic extract of V cinerea has been found to effectively inhibit tumor nodule formation. Tumor nodules are the metastatic colonies of B16F-10 melanoma cells, and they promote lung fibrosis and collagen deposition in the lung. This inhibition of tumor nodules correlates with an increase in the life span of the metastatic tumor-bearing animals.
The state of lung fibrosis was evaluated by estimating the lung collagen hydroxyproline content because during lung fibrosis, collagen is deposited massively in the alveolus of the lungs. A part of the collagen (15%-30%) is hydroxyproline, 59 which causes reduction in pulmonary function. In the V cinerea-treated group there was a significant reduction in the lung collagen hydroxyproline content as compared with tumor-bearing controls.
In the tumor cells, oxidation of the primary alcohol group of aldoses of sugar derivatives occurs, yielding uronic acid. This uronic acid leads to the formation of glucuronic acid lactone, which is an esterified form of uronic acid. In the presence of glucuronic acid lactone, prolyl hydroxylase enzyme converts the prohydroxyproline to hydroxyproline. Glucuronic acid lactone also activates fiber formation from collagen during fibrosis. Hexosamine is a significant compound in lung tumor cells. It plays an important role in the synthesis of N-acetyl neuraminic acid (sialic acid), which is a component of glycolipids present on the surface of tumor cells. 59 Treatment with V cinerea could reduce the amount of uronic acid, hexosamine, and sialic acid in tumor-bearing animals, indicating its inhibitory effect on metastasis.
The metastatic property of tumor cells is highly upregulated with elevated levels of sialic acid. 60 GGT, a marker of cellular proliferation, was increased in the serum of tumorbearing animals compared with its level in normal animals. glutathione (GSH) is synthesized intracellularly and provides energy to the tumor cells by GGT. GGT catalyzes this GSH breakdown. 61 Both sialic acid and GGT are direct markers of proliferative, metastatic cells. Treatment with V cinerea led to a significant reduction in serum sialic acid and γ-glutamyl transpeptidase content, indicating decreased incidence of tumor cell proliferation and metastasis.
Cytokines are a large family of soluble proteins, which serve as mediators of immune responses, participating in the communication and regulation of inflammatory responses. 62 Figure 7 . Effect of Vernonia cinerea on MMP-2 and MMP-9 production by B16F-10 melanoma cells: A. Condition medium from untreated B16F-10 melanoma cells without trypsin activation. B. Condition medium from untreated B16F-10 melanoma cells after trypsin activation. C. Condition medium from untreated B16F-10 melanoma cells after trypsin activation + EDTA. D. Condition medium from pretreated B16F-10 melanoma cells (0.5 mg/mL V cinerea) after trypsin activation. E. Condition medium from pretreated B16F-10 melanoma cells (1 mg/mL V cinerea) after trypsin activation. F. Condition medium from pretreated B16F-10 melanoma cells (2 µg/ml V cinerea) after trypsin activation Several inflammatory cytokines have been linked with tumorigenesis, which suggests that inflammation is associated with cancer development. 63 Numerous studies have indicated that tumor cells exhibit an elevation in constitutive production of the proinflammatory cytokines such as TNF-a, IL-1b, IL-6, and GM-CSF. More recently, some cytokines have also been implicated as putative mediators of some metastases. 64, 65 The basis for constitutive expression of these cytokines during tumor progression is unknown. Treatment with V cinerea significantly downregulated the production and expression of these proinflam matory cytokines.
MMPs are a family of zinc-dependent endoproteinases that are capable of degrading almost all the components of the ECM and thereby upregulating invasion and metastasis. 66, 67 Among the MMPs reported earlier, MMP-2 and MMP-9 are key enzymes for degrading type IV collagen, which is a major component of the basement membrane. 68, 69 Several experiments also proved that MMPs not only break down the physical barrier of ECM but also modulate the growth factors and cytokines stored in the ECM, which may promote neoplastic progression. 59 The result of zymographic analysis indicates that administration of V cinerea inhibited the activation of MMPs, thereby, inhibiting the invasion of B16F-10 melanoma cells through the collagen matrix. TIMP inhibits MMP activity, thereby, suppressing tumor invasion and metastasis. 70 Studies in experimental mouse models have revealed that enhanced TIMP expression can decrease metastasis and inhibit angiogenesis. 71 MMPs are also inhibited by common chelators. 72 Mouse studies indicate that when MMP2 is lacking or TIMP-1 is overproduced, formation of new tumors decreases. 73 In the present study, V cinerea treatment downregulated the expression of MMP-2 and MMP-9 as well as upregulated the expression of TIMP-1 and TIMP-2, indicating its regulatory effect on the inhibition of MMP.
The nm 23 gene was first identified as a gene whose expression was reduced in highly metastatic rodent tumors relative to poorly metastatic tumor cells. 74 Altered expression of this putative metastatic suppressor gene, nm23, 74, 75 is considered to play an important role during the acquisition of metastatic ability. Altered expression of prolyl hydroxylase and lysyl oxidase, the enzymes that catalyze the cross-linking in ECM, has been identified in various tumors. 76, 77 V cinerea treatment downregulated the expression of prolyl hydroxylase and lysyl oxidase and upregulated the expression of the metastatic suppressor gene, nm23, in tumor-bearing animals.
The ERK signaling pathway, also known as the mitogenactivated protein kinase pathway, is a major determinant in the control of cell growth, cell differentiation, and cell survival. This pathway, which operates downstream of Ras, is often upregulated in tumors and represents an attractive target for anticancer therapy. 78, 79 Inhibition of the ERK pathway is expected to result in antimetastatic as well as antiangiogenic effects. 80 VEGF, a proangiogenic factor, is regarded as one of the earliest and most important signals to regulate multistep cascade of tumor angiogenesis and preferably stimulates the proliferation and migration of endothelial cells and induces the expression of metalloproteinases. 81 Overexpression of VEGF in tumor cells enhances tumor growth and metastasis in several animal models by stimulating vascularization. In this study, the expression of k-ras, ERK-1, ERK-2, and VEGF have been downregulated by treatment with V cinerea. These results show that V cinerea could inhibit all the pathways that link the MMPs and VEGF to tumor survival, proliferation, and invasion.
The above experimental evidence shows that V cinerea inhibits the metastatic growth of B16F-10 melanoma cells in a mouse model. V cinerea inhibited tumor cell invasion and metastasis by regulating MMPs, VEGF, prolyl hydroxylase, lysyl oxidase, ERK-1, ERK-2, TIMPs, nm23, and proinflammatory cytokine gene expression in metastatic lung tissue.
